首站-论文投稿智能助手
典型文献
Histological assessment based on liver biopsy:the value and challenges in NASH drug development
文献摘要:
Nonalcoholic steatohepatitis(NASH)is increasingly recognized as a serious disease that can lead to cirrhosis,hepatocellular carcinoma(HCC),and death.However,there is no effective drug to thwart the progression of the disease.Development of new drugs for NASH is an urgent clinical need.Liver biopsy plays a key role in the development of new NASH drugs.Histological findings based on liver biopsy are currently used as the main inclusion criteria and the primary therapeutic endpoint in NASH clinical trials.However,there are inherent challenges in the use of liver biopsy in clinical trials,such as evaluation reliability,sampling error,and invasive nature of the procedure.In this article,we review the advantages and value of liver histopathology based on liver biopsy in clinical trials of new NASH drugs.We also discuss the challenges and limitations of liver biopsy and identify future drug development directions.
文献关键词:
作者姓名:
Xiao-fei Tong;Qian-yi Wang;Xin-yan Zhao;Ya-meng Sun;Xiao-ning Wu;Li-ling Yang;Zheng-zhao Lu;Xiao-juan Ou;Ji-dong Jia;Hong You
作者机构:
Liver Research Center,Beijing Friendship Hospital,Capital Medical University,Beijing Key Laboratory of Translational Medicine on Liver Cirrhosis,National Clinical Research Center of Digestive Diseases,Beijing 100050,China
引用格式:
[1]Xiao-fei Tong;Qian-yi Wang;Xin-yan Zhao;Ya-meng Sun;Xiao-ning Wu;Li-ling Yang;Zheng-zhao Lu;Xiao-juan Ou;Ji-dong Jia;Hong You-.Histological assessment based on liver biopsy:the value and challenges in NASH drug development)[J].中国药理学报(英文版),2022(05):1200-1209
A类:
thwart
B类:
Histological,assessment,liver,biopsy,value,challenges,NASH,development,Nonalcoholic,steatohepatitis,increasingly,recognized,serious,disease,that,can,lead,cirrhosis,hepatocellular,carcinoma,HCC,death,However,there,effective,progression,Development,new,drugs,urgent,clinical,need,Liver,plays,key,role,findings,are,currently,used,main,inclusion,criteria,primary,therapeutic,endpoint,trials,inherent,such,evaluation,reliability,sampling,error,invasive,nature,procedure,In,this,article,review,advantages,histopathology,We,also,discuss,limitations,identify,future,directions
AB值:
0.51035
相似文献
Molecular pathogenesis of acetaminophen-induced liver injury and its treatment options
Xiaopeng CAI;Huiqiang CAI;Jing WANG;Qin YANG;Jun GUAN;Jingwen DENG;Zhi CHEN-State Key Laboratory for Diagnosis and Treatment of Infectious Diseases,National Clinical Research Center for Infectious Diseases,Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Department of Clinical Medicine,University of Aarhus,Palle Juul-Jensens Boulevard 82,8200 Aarhus N,Denmark;Department of Pathology,Key Laboratory of Disease Proteomics of Zhejiang Province,Zhejiang University School of Medicine,Hangzhou 310058,China;Department of Pathology,Women’s Hospital,Zhejiang University School of Medicine,Hangzhou 310058,China
Mongolian medicine in treating type 2 diabetes mellitus combined with nonalcoholic fatty liver disease via FXR/LXR-mediated P2X7R/NLRP3/NF-κB pathway activation
Shuyin Bao;Xiuzhi Wang;Qianqian Ma;Chengxi Wei;Jixing Nan;Wuliji Ao-Institute of Pharmaceutical Chemistry and Pharmacology,Inner Mongolia Minzu University,Tongliao 028000,China;Inner Mongolia Key Laboratory of Mongolian Medicine Pharmacology for Cardio-Cerebral Vascular System,Tongliao 028000,China;Jilin Key Laboratory for Traditional Chinese Korean Medicine,College of Pharmacy,Yanbian University,Yanji 133002,China;Department of Medicines and Foods,Tongliao Vocational College,Tongliao 028000,China;Research and development center,Inner Mongolia Research Institute of Traditional Mongolian Medicine Engineering Technology,Tongliao 028000,China;Mongolian Medicine R&D National Local Union Engineering Research Center,Inner Mongolia Minzu University,Tongliao 028000,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。